Innovage Holding Corp. (INNV)

$3.91

-0.19

(-4.63%)

Market is closed - opens 7 PM, 15 Apr 2024

Insights on Innovage Holding Corp.

  • Increasing Revenue

    Revenue is up for the last 5 quarters, 167.45M → 188.89M (in $), with an average increase of 3.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -11.17M → -3.44M (in $), with an average increase of 103.7% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 55.3% return, outperforming this stock by 100.5%

  • Vs THC

    In the last 3 years, Tenet Healthcare Corp.  has given 20.5% return, outperforming this stock by 104.7%

Performance

  • $3.91
    $4.15
    $3.91
    downward going graph

    0.0%

    Downside

    Day's Volatility :5.78%

    Upside

    5.78%

    downward going graph
  • $3.88
    $8.05
    $3.91
    downward going graph

    0.77%

    Downside

    52 Weeks Volatility :51.8%

    Upside

    51.43%

    downward going graph

Returns

PeriodInnovage Holding Corp.Sector (Health Care)Index (Russel 2000)
3 Months
-33.16%
-1.1%
0.0%
6 Months
-34.18%
6.7%
0.0%
1 Year
-45.24%
3.2%
-0.7%
3 Years
-84.24%
17.2%
-21.3%

Highlights

Market Capitalization
557.2M
Book Value
$2.1
Earnings Per Share (EPS)
-0.23
PEG Ratio
0.0
Wall Street Target Price
6.75
Profit Margin
-4.38%
Operating Margin TTM
-0.95%
Return On Assets TTM
-3.66%
Return On Equity TTM
-10.74%
Revenue TTM
720.8M
Revenue Per Share TTM
5.31
Quarterly Revenue Growth YOY
12.8%
Gross Profit TTM
475.8M
EBITDA
-14.7M
Diluted Eps TTM
-0.23
Quarterly Earnings Growth YOY
-0.88
EPS Estimate Current Year
-0.16
EPS Estimate Next Year
0.05
EPS Estimate Current Quarter
-0.03
EPS Estimate Next Quarter
-0.02

Analyst Recommendation

Hold
    0
    0%Buy
    66%Hold
    33%Sell
Based on 9 Wall street analysts offering stock ratings for Innovage Holding Corp.(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
6
6
6
Sell
3
3
3

Analyst Forecast

What analysts predicted

Upside of 72.63%

Current $3.91
Target $6.75

Company Financials

FY18Y/Y Change
Revenue
465.6M
↑ 5181.47%
Net Income
19.6M
↓ 401.01%
Net Profit Margin
4.2%
↑ 77.97%
FY19Y/Y Change
Revenue
567.2M
↑ 21.81%
Net Income
26.3M
↑ 34.22%
Net Profit Margin
4.63%
↑ 0.43%
FY20Y/Y Change
Revenue
637.8M
↑ 12.45%
Net Income
-44.0M
↓ 267.39%
Net Profit Margin
-6.9%
↓ 11.53%
FY21Y/Y Change
Revenue
637.8M
↑ 0.0%
Net Income
-44.7M
↑ 1.71%
Net Profit Margin
-7.01%
↓ 0.11%
FY22Y/Y Change
Revenue
698.6M
↑ 9.54%
Net Income
-8.0M
↓ 82.21%
Net Profit Margin
-1.14%
↑ 5.87%
FY23Y/Y Change
Revenue
688.1M
↓ 1.51%
Net Income
-40.7M
↑ 410.97%
Net Profit Margin
-5.91%
↓ 4.77%
Q3 FY22Q/Q Change
Revenue
171.2M
↓ 0.95%
Net Income
-13.7M
↑ 1.23%
Net Profit Margin
-8.0%
↓ 0.17%
Q4 FY22Q/Q Change
Revenue
167.5M
↓ 2.2%
Net Income
-10.5M
↓ 23.01%
Net Profit Margin
-6.3%
↑ 1.7%
Q1 FY23Q/Q Change
Revenue
172.5M
↑ 3.04%
Net Income
-7.3M
↓ 30.69%
Net Profit Margin
-4.24%
↑ 2.06%
Q2 FY23Q/Q Change
Revenue
176.9M
↑ 2.51%
Net Income
-11.2M
↑ 52.9%
Net Profit Margin
-6.32%
↓ 2.08%
Q3 FY23Q/Q Change
Revenue
182.5M
↑ 3.17%
Net Income
-10.3M
↓ 7.81%
Net Profit Margin
-5.65%
↑ 0.67%
Q4 FY23Q/Q Change
Revenue
188.9M
↑ 3.51%
Net Income
-3.4M
↓ 66.55%
Net Profit Margin
-1.82%
↑ 3.83%
FY18Y/Y Change
Total Assets
363.2M
↑ 3922.12%
Total Liabilities
281.8M
↑ 3366.94%
FY19Y/Y Change
Total Assets
409.6M
↑ 12.77%
Total Liabilities
301.9M
↑ 7.13%
FY20Y/Y Change
Total Assets
531.8M
↑ 29.81%
Total Liabilities
173.8M
↓ 42.43%
FY21Y/Y Change
Total Assets
531.8M
↑ 0.0%
Total Liabilities
173.8M
↑ 0.0%
FY22Y/Y Change
Total Assets
555.6M
↑ 4.48%
Total Liabilities
201.9M
↑ 16.15%
FY23Y/Y Change
Total Assets
567.4M
↑ 2.12%
Total Liabilities
252.6M
↑ 25.12%
Q3 FY22Q/Q Change
Total Assets
585.0M
↑ 5.29%
Total Liabilities
243.7M
↑ 20.74%
Q4 FY22Q/Q Change
Total Assets
546.1M
↓ 6.64%
Total Liabilities
214.3M
↓ 12.06%
Q1 FY23Q/Q Change
Total Assets
569.4M
↑ 4.27%
Total Liabilities
243.8M
↑ 13.73%
Q2 FY23Q/Q Change
Total Assets
567.4M
↓ 0.36%
Total Liabilities
252.6M
↑ 3.61%
Q3 FY23Q/Q Change
Total Assets
545.6M
↓ 3.84%
Total Liabilities
240.5M
↓ 4.76%
Q4 FY23Q/Q Change
Total Assets
534.3M
↓ 2.08%
Total Liabilities
231.3M
↓ 3.85%
FY18Y/Y Change
Operating Cash Flow
25.9M
↓ 1197.25%
Investing Cash Flow
-52.5M
↑ 90384.48%
Financing Cash Flow
37.3M
↓ 1284.12%
FY19Y/Y Change
Operating Cash Flow
43.8M
↑ 69.18%
Investing Cash Flow
-11.7M
↓ 77.72%
Financing Cash Flow
21.2M
↓ 43.15%
FY20Y/Y Change
Operating Cash Flow
-7.5M
↓ 117.22%
Investing Cash Flow
-19.5M
↑ 67.15%
Financing Cash Flow
116.2M
↑ 447.4%
FY21Y/Y Change
Operating Cash Flow
-7.5M
↑ 0.0%
Investing Cash Flow
-40.2M
↑ 105.92%
Financing Cash Flow
116.2M
↑ 0.0%
FY22Y/Y Change
Operating Cash Flow
27.3M
↓ 461.71%
Investing Cash Flow
-69.5M
↑ 72.77%
Financing Cash Flow
-6.3M
↓ 105.44%
Q3 FY22Q/Q Change
Operating Cash Flow
13.1M
↑ 304.78%
Investing Cash Flow
-7.7M
↓ 53.99%
Financing Cash Flow
-1.7M
↑ 1.21%
Q4 FY22Q/Q Change
Operating Cash Flow
-35.1M
↓ 367.52%
Investing Cash Flow
-52.0M
↑ 577.88%
Financing Cash Flow
-1.7M
↑ 0.66%
Q1 FY23Q/Q Change
Operating Cash Flow
29.1M
↓ 182.79%
Investing Cash Flow
-5.2M
↓ 90.01%
Financing Cash Flow
-2.1M
↑ 27.04%
Q2 FY23Q/Q Change
Operating Cash Flow
13.2M
↓ 54.77%
Investing Cash Flow
-5.2M
↑ 0.0%
Financing Cash Flow
-2.4M
↑ 13.27%

Technicals Summary

Sell

Neutral

Buy

Innovage Holding Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Innovage Holding Corp.
Innovage Holding Corp.
-8.75%
-34.18%
-45.24%
-84.24%
30.33%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
-6.32%
6.3%
-20.94%
-51.19%
-55.7%
Hca Holdings, Inc.
Hca Holdings, Inc.
-0.6%
34.83%
18.1%
69.06%
154.01%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
0.4%
85.55%
55.07%
92.3%
248.27%
Universal Health Services Inc.
Universal Health Services Inc.
-3.55%
32.27%
22.66%
21.28%
25.65%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
-4.1%
74.9%
55.34%
20.5%
136.4%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Innovage Holding Corp.
Innovage Holding Corp.
44.59
NA
0.0
-0.16
-0.11
-0.04
NA
2.1
Fresenius Medical Care Ag
Fresenius Medical Care Ag
20.55
20.55
0.41
2.09
0.05
0.03
0.03
46.42
Hca Holdings, Inc.
Hca Holdings, Inc.
17.27
17.27
1.46
20.58
0.12
0.11
0.01
-6.68
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
17.83
17.83
2.22
6.03
0.26
0.06
NA
16.09
Universal Health Services Inc.
Universal Health Services Inc.
16.64
16.64
1.87
13.45
0.12
0.05
0.0
91.53
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.8
17.8
1.18
8.94
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Innovage Holding Corp.
Innovage Holding Corp.
Hold
$557.2M
30.33%
44.59
-4.38%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$11.1B
-55.7%
20.55
2.57%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$86.7B
154.01%
17.27
8.07%
Tenet Healthcare Corp. 
Tenet Healthcare Corp. 
Buy
$10.2B
248.27%
17.83
2.97%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.5B
25.65%
16.64
5.03%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$11.5B
136.4%
17.8
5.7%

Institutional Holdings

  • T. Rowe Price Investment Management,Inc.

    3.44%
  • Coliseum Capital Management LLC

    3.29%
  • Vanguard Group Inc

    1.35%
  • Kent Lake Capital LLC

    1.24%
  • BlackRock Inc

    0.98%
  • Geode Capital Management, LLC

    0.33%

Company Information

innovage helps seniors age in their own homes with dignity through the program of all-inclusive care for the elderly (pace). innovage is dedicated to expanding this successful program to serve as many seniors as possible across the country. we hire exceptional people for our programs in california, colorado, new mexico, pennsylvania, and virginia.our mission is to sustain and enhance the independence and quality of life for those we serve, on their terms. our purpose is to help older adults remain mobile, prolong their health, and continue living in their own homes.

Organization
Innovage Holding Corp.
Employees
2100
CEO
Mr. Patrick Blair
Industry
Pharmaceuticals: Other

FAQs